2017 Under the Radar: RiskGenius crafts AI tool for insurers

August 29, 2017  |  Bobby Burch

The RiskGenius team

Editor’s note: Startland News picked 10 early-stage firms to spotlight for its annual Under the Radar startups list. The following is one of 2017’s companies. To view the full list, click here.

RiskGenius — previously known as ClaimKit — grew from an initial concept to improve insurance claim documentation.

Following careers with surety companies and litigating insurance claims, RiskGenius co-founders Chris Cheatham and Doug Reiser set out to build document management software to tackle the mountains of messy paperwork with collecting, organizing and delivering insurance claims.

Eventually, the firm pivoted in 2015 to focus on policy analysis and incorporated a machine learning tool that’s differentiating it among tech providers for insurance companies. The proprietary tool is named Johannes, which allows RiskGenius clients to tap custom algorithms and workflow tools to better understand policy language and create more efficient underwriting workflows.

The RiskGenius platform provides several automation tools to help the manual reviewing and comparing of insurance policies, which is a time-consuming, error-prone process. A compliance tool helps better connect underwriters with legal teams for approval and approve policy language more efficiently. The platform also features an analytics tool to identify language trends across policies. The data helps to inform insights from policy language and can expedite the underwriting process.

In 2016, RiskGenius raised $2.78 million to accelerate the development of its tech. The company now has 10 full-time staff members.

startland-tip-jar

TIP JAR

Did you enjoy this post? Show your support by becoming a member or buying us a coffee.

Tagged ,
Featured Business
    Featured Founder

      2017 Startups to Watch

        stats here

        Related Posts on Startland News

        David Lintz, RFP360

        Strategic investment from Five Elms Capital comes with new CEO for RFP360

        By Tommy Felts | January 16, 2019

        A freshly announced strategic growth investment is expected to boost RFP360’s sales, marketing and product development, as well as paving the way for added leadership at the Kansas City-based tech startup. Financial details of the deal with Five Elms Capital were not disclosed, but the move comes in conjunction with the arrival of former Perceptive…

        Lisa Bledsoe, Tea-Biotics Kombucha

        2019 Startups to Watch: Tea-Biotics Kombucha taps into thirst for better beverages

        By Tommy Felts | January 14, 2019

        Editor’s note: Startland selected 12 Kansas City firms to spotlight for its annual Startups to Watch list. The following is one of 2019’s companies. Click here to view the full, ranked list of Startups to Watch. Tea-Biotics Kombucha’s elevator pitch: Tea-Biotics Kombucha is a live, probiotic, organic beverage that is handcrafted locally in Kansas City…

        Rachel Smith and Jeff Rohr, SquareOffs

        2019 Startups to Watch: SquareOffs curing ‘comment chaos’ with two-way conversations

        By Tommy Felts | January 14, 2019

        Editor’s note: Startland selected 12 Kansas City firms to spotlight for its annual Startups to Watch list. The following is one of 2019’s companies. Click here to view the full, ranked list of Startups to Watch. SquareOffs’ elevator pitch: SquareOffs is a microdebate platform used by online publishers and brands to promote meaningful conversation, increase engagement,…

        Dr. Nicholas Franano, Metactive

        2019 Startups to Watch: Metactive patience set to payoff for medical device patients

        By Tommy Felts | January 14, 2019

        Editor’s note: Startland selected 12 Kansas City firms to spotlight for its annual Startups to Watch list. The following is one of 2019’s companies. Click here to view the full, ranked list of Startups to Watch. Metactive’s elevator pitch: Medical tech company that makes catheter-based devices used to treat cardiovascular disease, stroke, cancer, and life-threatening…